Active Clinical Trials

If you would like to be considered for one of the clinical trials listed below please contact:

Kristy Averette, MSN, RN, CCRP
Research Practice Manager
kristy.averette@duke.edu
Phone: 919-681-5797 

Gorlin Syndrome

  • Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults with Gorlin Syndrome.

 

Advanced Skin Cancers

  • A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients with Advanced Cutaneous Malignancies.

 

Hidradenitis Suppurativa (HS)

 

  • Biorepository of Patients with Hidradenitis Suppurativa (HS): Determination of potential predictors and moderators of treatment response in patients with HS.

 

  • A Study to Test the Long-term Treatment of Bimekizumab in Study Participants with Moderate to Severe Hidradenitis Suppurativa (BE HEARD EXT).

 

  • A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS).

 

  • A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa.

Psoriasis

  • A Multicenter, Randomized, Double-Blind, Placebo and Active Comparator Controlled Phase 3 Study to Evaluate the Efficacy and Safety of ESK-001 in Patients with Moderate to Severe Plaque Psoriasis (ONWARD1)

Cutaneous Sarcoidosis

  • A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis

Lupus

  • A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/​or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/​or Intolerant to Antimalarial Therapy (AMETHYST).